Press release

PGXperts GmbH

HMG Systems Engineering GmbH spins off pharmacogenetics department into PGXperts GmbH

Fürth, May 7, 2024 – HMG Systems Engineering announces the transfer of its innovation in the field of pharmacogenetics to a new company: PGXperts GmbH. This spin-off marks an important milestone after nine years of research and development in the field of personalized medication, which was rewarded with high customer acceptance in 2023.

The global demand for digital solutions for personalized medication, taking pharmacogenetics into account, has risen sharply in recent years. The spin-off of the business unit is an important step towards meeting this demand and making the benefits of personalized medication accessible to all patients in the future with the help of PGXperts.

HMG Systems Engineering will continue to offer its core business, engineering services for the digital transformation in the areas of e-health, mobility and renewable energies.

"The PGXperts system offers a pioneering approach by digitizing drug therapy and using 'Omics' to enable personalized treatment plans as part of a patient-centered approach," says Herna Munoz-Galeano, founder and Managing Director of HMG Systems Engineering GmbH. "We are proud to develop the PGXperts system in Fürth and thus strengthen the innovative power of our Nuremberg-Central Franconia region."